Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,016.00
Bid: 12,016.00
Ask: 12,018.00
Change: -140.00 (-1.15%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,098.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Synthomer lifts outlook on strong momentum

Mon, 19th Jul 2021 07:47

(Alliance News) - Stocks in London are set to start the week on the back foot amid concerns over rising coronavirus cases across the globe.

In early UK company news, Ultra Electronics unveiled a jump in interim profit in a stronger-than-expected set of results, Synthomer boosted its 2021 earnings guidance, and AstraZeneca's Imfinzi received Chinese approval.

IG says futures indicate the FTSE 100 to open down 57.49 points, or 0.8%, at 6,950.60 on Monday. The index of large-caps closed down 3.93 points, or 0.1%, at 7,008.09 on Friday.

The soft start for London follows a weak performance for equities in Asia on Monday.

In Tokyo, the Nikkei 225 index ended down 1.3%. In China, the Shanghai Composite was flat, while the Hang Seng index in Hong Kong was down 1.7%. The S&P/ASX 200 in Sydney ended down 0.9%.

In the US on Friday, Wall Street also had ended lower, with the Dow Jones Industrial Average down 0.9%, the S&P 500 down 0.8%, and the Nasdaq Composite down 0.8%.

"Equity markets are front and centre in Asia this morning, as increasing nerves about the delta-variant Covid-19 are sapping recovery hopes across the Asia-Pacific. Of course, you can choose your poison on that front globally, with the US, Europe, and the UK also experiencing rises in cases," said Jeffrey Halley, senior market analyst at Oanda.

Despite daily coronavirus cases surging, the UK government on Monday lifted pandemic restrictions on daily life in England, scrapping all social distancing in a step slammed by opposition parties and some scientists as a dangerous leap into the unknown.

From midnight, nightclubs were able to reopen and other indoor venues allowed to run at full capacity, while legal mandates covering the wearing of masks and working from home were scrapped.

UK Prime Minister Boris Johnson – who is self-isolating after his health minister was infected – urged the public to remain prudent and for any laggards to join the two-thirds of UK adults who are now fully vaccinated.

He defended the reopening – dubbed 'freedom day' by some media – despite some scientists' misgivings after daily infection rates in Britain topped 50,000, behind only Indonesia and Brazil.

Oanda's Halley said he expects "nerves" over the reopening decision to cap gains for sterling this week.

The pound was quoted at USD1.3751 early Monday, slipping from USD1.3788 at the London equities close on Friday.

In early UK company news, AstraZeneca said its Imfinzi has been approved in China for the treatment of extensive-stage small cell lung cancer.

Small cell lung cancer is a highly aggressive, fast-growing form of lung cancer, Astra said. The approval by China's National Medical Products Administration was based on positive results from the Caspian phase three trial, with safety and efficacy in the China cohort of patients consistent with the global results.

Ultra Electronics reported a stronger-than-expected first half, leaving the aerospace and defence engineering company confident on its prospects.

Revenue for the six months to July 2 slipped 2.1% to GBP404.5 million from GBP413.1 million a year before. However, on an organic basis, revenue rose 4.7%.

The revenue performance was a strong one "particularly given the mainly Covid-19 driven operational inefficiencies and supply chain disruption experienced in Q1 2021, which are now broadly resolved."

Pretax profit jumped 55% to GBP46.2 million from GBP29.8 million.

Looking ahead, Ultra Electronics said its focused strategy and improved execution allows for increased confidence in delivering above-market growth.

Chief Executive Simon Pryce said: "Our Focus; Fix; Grow transformation programme is already delivering ahead of plan and we are now more confident in our improvement potential with a better payback than originally anticipated. This should allow us to accelerate top-line growth and gain market share through additional investment in research & development, improved operational delivery and by further optimising our cost base."

Synthomer boosted its 2021 earnings guidance following good trading momentum in its first half.

The chemicals company said it has continued to see strong trading momentum across the business with volumes and unit margins ahead of a year ago in all divisions. The Nitrile latex business has been performing well, it added, driven by "exceptional demand" due to the pandemic.

As a result, Synthomer now expects 2021 earnings before interest, tax, depreciation and amortisation in excess of GBP500 million, compared to its previous guidance of above GBP450 million. In 2020, the company recorded Ebitda of GBP259.4 million.

"Synthomer continues to expect that the Nitrile latex business will return to more normalised levels during 2022," it added.

All Active Asset Capital said it is in "constructive discussions" with Audioboom about a possible offer for the podcasts producer at GBP12.00 per share.

If an offer is made, AAA said, it would consist of 12.5 new AAA shares and 200p in cash per Audioboom share. This would value Audioboom shares at GBP12.00 each, a premium of 36% to Friday's closing price of 885p.

AAA has received irrevocable undertakings to accept such an offer in respect of 4.1 million Audioboom shares, representing 26% of its share capital.

"The directors believe the combination of AAA and Audioboom would create a compelling portfolio of innovative, high growth technology investments that could create significant new accretive value for the shareholders of both companies in the future," said AAA.

There can be no certainty that any firm offer will be made, it stressed.

Separately, AAA said that Allenby has resigned as nominated advisor and broker due to a conflict of interest. AAA shares remain suspended, and it has one month to appoint a new nomad under AIM rules.

The euro traded at USD1.1803 early Monday, soft on USD1.1810 late Friday. Against the safe-haven Japanese yen, the dollar fell to JPY109.96 versus JPY110.15.

Gold was quoted at USD1,806.16 an ounce early Monday, down against USD1,813.55 on Friday.

Brent oil was trading at USD73.00 a barrel, soft on USD73.27 late Friday after the world's leading oil producers agreed on Sunday to continue to modestly boost output from August.

In a rare challenge to OPEC leader Saudi Arabia, the UAE had rejected a proposed deal earlier this month as "unjust", leading to a stalemate. But in a compromise, Sunday's discussions agreed to adjust output quotas next May for the UAE, Iraq, Kuwait, Russia and Saudi Arabia itself, meaning their actual cuts will be less.

Saudi Energy Minister Prince Abdulaziz bin Salman, who chairs the OPEC group, declined to say how the new quotas were decided and beneficiaries chosen, saying it had been part of "consensus building".

The economic events calendar on Monday has eurozone construction output at 1000 BST.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
Today 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.